The question sounds precise, which is part of its appeal: should you take green tea extract during your follicular phase rather than your luteal phase, because your liver clears estrogen differently depending on where you are in your cycle? It is the kind of targeted advice that feels sophisticated. It also goes beyond what the published literature actually supports.
This piece works through the biology - what estrogen clearance involves, what EGCG (epigallocatechin-3-gallate, the primary catechin in green tea extract) does to estrogen signaling, and what the human trials have actually found. The cycle-timing premise gets examined specifically, because the answer matters for anyone deciding how to use this supplement.
How the body processes estrogen
Estrogen does not simply disappear after it acts on target tissue. It is metabolized primarily in the liver through cytochrome P450 (CYP) enzymes - principally CYP1A2, CYP1B1, and CYP3A4 - that hydroxylate the estrogen molecule before it is conjugated and excreted through bile or urine.
That hydroxylation step produces two main metabolite classes researchers have studied as biomarkers. The 2-hydroxyestrone (2-OHE1) pathway yields a metabolite with relatively low estrogenic activity. The 16-alpha-hydroxyestrone (16-alpha-OHE1) pathway yields a metabolite that retains meaningful estrogenic activity at the receptor. Researchers have proposed that a higher urinary ratio of 2-OHE1 to 16-alpha-OHE1 marks favorable estrogen metabolism. One prospective study in premenopausal and postmenopausal women found a link between higher 2:16 ratios and lower breast cancer risk, though the link was not statistically significant across all subgroups examined (Estrogen metabolism and risk of breast cancer, Cancer Epidemiol Biomarkers Prev, 2000).
Researchers have since contested that association. A 2020 review concluded that the evidence for the 2:16 ratio as a predictive biomarker for breast cancer remains insufficient and that the hypothesis lacks clinical support at this time (The 2-/16-alpha-Hydroxylated Estrogen Ratio - Breast Cancer Risk Hypothesis, Cancers, 2020). The ratio is measurable. Whether shifting it through supplementation produces meaningful health outcomes is a different question - and one that remains open.
What EGCG actually does at the estrogen receptor
Green tea catechins, and EGCG in particular, are often called modulators of estrogen activity. That's mechanistically accurate. However, supplement marketing often mischaracterizes what the mechanism actually does.
EGCG appears to compete with 17-beta-estradiol for binding at estrogen receptor alpha (ER-alpha) in cell culture models, and studies show it downregulates ER-alpha expression in estrogen-sensitive cell lines in vitro. This is receptor modulation - changing how cells respond to estrogen that's already circulating. It's different from speeding up estrogen clearance or shifting the 2:16 hydroxylation ratio upward. This distinction matters for anyone who's heard that EGCG will help their body eliminate excess estrogen more efficiently.
On the enzyme side, an in vitro study using human liver and intestinal microsomes found that green tea catechins inhibit several CYP isoforms, including CYP3A4 - one of the enzymes involved in estrogen hydroxylation - at pharmacological concentrations (Green tea catechins on cytochrome P450 activities in human liver and intestinal microsomes, Drug Metab Dispos, 2013). Inhibition of CYP3A4 could theoretically slow estrogen clearance rather than speed it up, though the concentrations tested exceeded what typically circulates after an oral supplement dose. The direction matters: the claim that EGCG speeds up estrogen removal doesn't match this enzyme-level data.
What the human trials show
Randomized controlled trials in women don't consistently show that green tea catechin supplementation changes circulating sex hormone levels.
A 2019 randomized, double-blind, placebo-controlled trial enrolled postmenopausal women at elevated breast cancer risk and assigned participants to green tea catechin extract providing 400 mg or 800 mg EGCG daily or to placebo for 12 months. The study found no significant influence on circulating estradiol, estrone, sex hormone-binding globulin, or IGF-1 (Green Tea Catechin Extract Supplementation Does Not Influence Circulating Sex Hormones, Cancer Prev Res, 2019). A two-month controlled green tea intervention in a similar postmenopausal population, using dose ranges of 400 to 800 mg EGCG, also reported no consistent pattern of change in estradiol, estrone, or testosterone (Effect of 2-month controlled green tea intervention on hormone levels in healthy postmenopausal women, Nutr Cancer, 2012).
A 2025 systematic review and meta-analysis examining green tea extracts and polyphenols in female hormone-dependent conditions found that results across trials remain heterogeneous, with menopausal status, baseline hormone levels, and supplementation duration accounting for much of the variability (Systematic review and meta-analysis, effects of green tea extracts in female hormone-dependent conditions, Nutrients, 2025). None of the trials included in that analysis randomized women by menstrual cycle phase, and no cycle-phase interaction effects were reported.
Does menstrual cycle phase change how your body metabolizes estrogen?
This is the more specific question, and it deserves a direct answer.
Estradiol concentrations fluctuate substantially across the cycle - peaking near ovulation and again in the mid-luteal phase. But the metabolic enzymes responsible for clearance do not track those peaks in a simple proportional way.
A 2021 study measuring CYP3A activity across the follicular, ovulatory, and luteal phases - using the urinary 6-beta-hydroxycortisol/cortisol ratio as an endogenous marker - found no statistically significant variation in CYP3A activity across those three phases (CYP3A activity during the menstrual cycle, Br J Clin Pharmacol, 2021). CYP3A4 is a principal enzyme in estrogen hydroxylation. If its activity does not meaningfully shift across the cycle, the biological rationale for a cycle-timed supplementation window weakens considerably.
Some pharmacokinetic literature suggests that exogenous estrogen - particularly oral contraceptive-dose estrogen - modulates CYP1A2 activity downward. Whether the natural mid-cycle estradiol rise produces a comparable, real-time alteration in CYP1A2 throughput in healthy cycling women, and whether EGCG interacts meaningfully with that shift, researchers haven't established. The premise may also get the physiology backwards: what changes across the cycle is mainly how much estrogen your body produces. Your liver clears each molecule at roughly the same rate.
Dose, safety, and what to watch for
The human trials examining hormonal effects used EGCG doses in the range of 400 to 800 mg per day. At or above 800 mg EGCG daily for four months or longer, a small proportion of individuals - typically under 10 percent in reviewed studies - showed elevated liver enzymes (ALT and AST). That risk appears higher when green tea extract is taken in a fasted state (LiverTox: Green Tea, National Library of Medicine).
If you're thinking about a standardized green tea extract, Ayurnomics Green Tea Daily 725 provides 725 mg green tea extract per serving and should be taken with food - important given the liver safety information above. Anyone taking medications metabolized by CYP enzymes, including certain statins, anticoagulants, or antidepressants, should talk to their doctor before starting any concentrated green tea extract.
For parallel reading on plant-derived compounds studied in the context of women's hormonal health, the Ayurnomics Journal pieces on spearmint tea and androgen modulation and on inositol ratios for PCOS examine adjacent evidence with the same level of citation detail.
The honest position
Green tea extract has genuine mechanistic interest for estrogen biology: receptor competition at ER-alpha, possible CYP enzyme modulation, and a measurable - if clinically debated - effect on the urinary estrogen metabolite ratio in some populations. What it doesn't have yet is a randomized trial showing that premenopausal women who time their EGCG intake to their follicular phase get meaningfully different hormonal outcomes than those who take it without thinking about their cycle. That study hasn't been done.
Cycle-syncing supplement protocols appeal to people because they sound precise. Precision needs evidence that matches the specific claim being made. For green tea extract and estrogen clearance, the current evidence base supports more research - not a dosing schedule based on your cycle phase.
If hormonal balance is a goal area for you, the Hormonal Balance collection brings together the ingredients most studied in this space, with sourcing and dosing context for each.
Envie de découvrir d'autres articles comme celui-ci ? Rejoignez le Cercle Privilégié et recevez un article soigné chaque dimanche.